Leif Hembre went into last summer focused on beating prostate cancer. The St. Paul resident got the good news he wanted: treatment at Mayo Clinic worked. The celebration did not last. Instead of closing the book on his care, Hembre suddenly found himself staring down a massive bill after his insurer flagged Mayo as out of network, turning routine phone calls and small checks into a months‑long fight over a balance big enough to upend his finances.
How the bills ballooned
According to Hembre, an April 2025 prostate cancer screening set off a quick chain of events: a biopsy, a diagnosis, and a recommendation for high‑dose‑rate brachytherapy. His radiation oncologist at Allina urged him to have the procedure done at Mayo Clinic. Hembre says he did what patients are always told to do and called his Medica health plan before locking anything in. He recalls a representative telling him Mayo was in-network, and Mayo scheduled HDR treatments for Aug. 21 and Aug. 28, 2025.
After the procedures, Medica began sending Hembre a series of small reimbursement checks and explanation‑of‑benefits forms. Meanwhile, Mayo treated some of the charges as his responsibility. By early December, Hembre says the clinic informed him his balance had climbed to $76,423 and that an appeal had been denied. The dispute pushed Medica to review a July call recording, after which the insurer told Hembre the claims would be covered in full and that he would be reimbursed. The ordeal was detailed by the Star Tribune.
The treatment he had
High‑dose‑rate (HDR) brachytherapy is a focused radiation treatment in which clinicians temporarily place radioactive material inside the prostate so high doses can be delivered over minutes rather than weeks. Patients typically undergo several short sessions. Mayo Clinic’s patient materials describe HDR and seed‑implant options and list expected side effects that can include urinary urgency and erectile dysfunction. As outlined by Mayo Clinic, HDR brachytherapy is a well‑established option for some people with early‑stage prostate cancer.
Why coverage gets messy
Insurance coverage rules can turn even straightforward cancer care into a bureaucratic obstacle course. Network restrictions, referrals and prior‑authorization requirements all play a role, and patients often have little visibility into how those decisions are made. Analysts who track claims denials and appeals say those denials, along with prior‑authorization hurdles, continue to create significant burdens for patients, even when the care itself is considered appropriate.
Recent data on marketplace plans shows how frequently insurers still reject claims and how rarely patients appeal, according to KFF. At the same time, some major insurers have publicly touted changes meant to streamline prior authorizations, though reporting shows those pledges have yet to fully erase delays and red tape, as covered by Axios.
What advocates recommend
Patient‑rights advocates say Hembre’s experience is a case study in why people need to treat every insurance call like it might someday end up as evidence. They recommend saving screenshots of online provider directories, asking insurers to confirm network status in writing and keeping meticulous notes about every interaction, including dates, times and the names of representatives.
Advocates who spoke to the Star Tribune said those habits can help protect patients when information from insurers turns out to be wrong. If a bill looks off, consumer groups and federal resources urge patients to request an itemized bill, file a formal appeal with their insurer and, if needed, reach out for outside help. Guidance from AARP and the federal CMS Medical Bill Rights portal highlights these steps and explains how to contact the federal No Surprises help desk or state insurance regulators.
Bottom line
Hembre says Medica’s decision to reverse course and cover the Mayo bills brought enormous relief, but the months of uncertainty left him drained and cautious. The outcome of his cancer treatment was what he had hoped for; the financial drama that followed was not. His case underscores how even when the medicine goes right, the paperwork can go very wrong, and how documentation, early appeals and sometimes a bit of outside advocacy can be as critical to peace of mind as the treatment plan itself.
